271 related articles for article (PubMed ID: 22926148)
1. Techniques for the optimization of facial and nonfacial volumization with injectable poly-l-lactic acid.
Lorenc ZP
Aesthetic Plast Surg; 2012 Oct; 36(5):1222-9. PubMed ID: 22926148
[TBL] [Abstract][Full Text] [Related]
2. The history behind the use of injectable poly-L-lactic acid for facial and nonfacial volumization: the positive impact of evolving methodology.
Vleggaar D; Fitzgerald R; Lorenc ZP
J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s32-4. PubMed ID: 24719075
[TBL] [Abstract][Full Text] [Related]
3. The evolution of injectable poly-L-lactic acid from the correction of HIV-related facial lipoatrophy to aging-related facial contour deficiencies.
Burgess C
J Drugs Dermatol; 2011 Sep; 10(9):1001-6. PubMed ID: 22052268
[TBL] [Abstract][Full Text] [Related]
4. A novel approach to structural facial volume replacement.
Sadick NS; Manhas-Bhutani S; Krueger N
Aesthetic Plast Surg; 2013 Apr; 37(2):266-76. PubMed ID: 23358580
[TBL] [Abstract][Full Text] [Related]
5. Poly-L-lactic acid injection for HIV-associated facial lipoatrophy: treatment principles, case studies, and literature review.
Kates LC; Fitzgerald R
Aesthet Surg J; 2008; 28(4):397-403. PubMed ID: 19083552
[TBL] [Abstract][Full Text] [Related]
6. Soft-tissue augmentation and the role of poly-L-lactic acid.
Vleggaar D
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):46S-54S. PubMed ID: 16936544
[TBL] [Abstract][Full Text] [Related]
7. Consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization.
Vleggaar D; Fitzgerald R; Lorenc ZP; Andrews JT; Butterwick K; Comstock J; Hanke CW; O'Daniel TG; Palm MD; Roberts WE; Sadick N; Teller CF
J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s44-51. PubMed ID: 24719078
[TBL] [Abstract][Full Text] [Related]
8. European expert recommendations on the use of injectable poly-L-lactic acid for facial rejuvenation.
Alessio R; Rzany B; Eve L; Grangier Y; Herranz P; Olivier-Masveyraud F; Vleggaar D
J Drugs Dermatol; 2014 Sep; 13(9):1057-66. PubMed ID: 25226006
[TBL] [Abstract][Full Text] [Related]
9. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring.
Lam SM; Azizzadeh B; Graivier M
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):55S-63S. PubMed ID: 16936545
[TBL] [Abstract][Full Text] [Related]
10. A decade of experience with injectable poly-L-lactic acid: a focus on safety.
Bartus C; William Hanke C; Daro-Kaftan E
Dermatol Surg; 2013 May; 39(5):698-705. PubMed ID: 23379657
[TBL] [Abstract][Full Text] [Related]
11. Nonsurgical rejuvenation of the aging face with injectable poly-L-lactic acid for restoration of soft tissue volume.
Schierle CF; Casas LA
Aesthet Surg J; 2011 Jan; 31(1):95-109. PubMed ID: 21239677
[TBL] [Abstract][Full Text] [Related]
12. Off Face Usage of Poly-L-Lactic Acid for Body Rejuvenation.
Jabbar A; Arruda S; Sadick N
J Drugs Dermatol; 2017 May; 16(5):489-494. PubMed ID: 28628686
[TBL] [Abstract][Full Text] [Related]
13. The need for consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization.
Vleggaar D; Fitzgerald R; Lorenc ZP
J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s28. PubMed ID: 24719073
[No Abstract] [Full Text] [Related]
14. Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience.
Butterwick K; Lowe NJ
J Am Acad Dermatol; 2009 Aug; 61(2):281-93. PubMed ID: 19615539
[TBL] [Abstract][Full Text] [Related]
15. The "smile-and-fill" injection technique: a dynamic approach to midface volumization.
Wang AS; Babalola O; Jagdeo J
J Drugs Dermatol; 2014 Mar; 13(3):288-90. PubMed ID: 24595573
[TBL] [Abstract][Full Text] [Related]
16. Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles.
Brandt FS; Cazzaniga A; Baumann L; Fagien S; Glazer S; Kenkel JM; Lowe NJ; Monheit GD; Narins RS; Rendon MI; Rohrich RJ; Werschler WP
Aesthet Surg J; 2011 Jul; 31(5):521-8. PubMed ID: 21719865
[TBL] [Abstract][Full Text] [Related]
17. Injectable fillers for volume replacement in the aging face.
Greco TM; Antunes MB; Yellin SA
Facial Plast Surg; 2012 Feb; 28(1):8-20. PubMed ID: 22418812
[TBL] [Abstract][Full Text] [Related]
18. Minimizing adverse events associated with poly-L-lactic acid injection.
Narins RS
Dermatol Surg; 2008 Jun; 34 Suppl 1():S100-4. PubMed ID: 18547172
[TBL] [Abstract][Full Text] [Related]
19. Poly-L-lactic acid: a new dimension in soft tissue augmentation.
Rotunda AM; Narins RS
Dermatol Ther; 2006; 19(3):151-8. PubMed ID: 16784514
[TBL] [Abstract][Full Text] [Related]
20. Poly-L-lactic acid facial rejuvenation: an alternative to autologous fat?
Buckingham ED
Facial Plast Surg Clin North Am; 2013 May; 21(2):271-84. PubMed ID: 23731588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
